» Download Public Reports
About 500 reports
- Industry report
- May 2012
- 14 pages
... Industry representative: Not possible for one individual to fully represent entire industry Our letter reaffirmed ditta S strength as the only global association representing medical imaging, which ...
April 2012
... Medicines in oncology, virology, inflammation, metabolism and cns. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche ...
March 2012
... Stage funds (public) 20%Technology transfer (federal & university) + incubators 2 innovation capital Invested before commercial success $100,000 - $2,500,000 Square4 seed capital $100,000 - $250 ...
March 2012
... Label products: the exclusive pharmacy products from the field of diagnostics are now also available in germany. With the high-quality and at the same time high-earnings medical devices, pharmacies can ...
March 2012
... Source: les echos, medtech business, snitem opportunities challenges france is facing an aging population Increase of chronic diseases Growing demand for orthopaedic devices such as knee ...
March 2012
... Little/ dti report 2004 first Product Breakthrough imagingelec.Med/respiratory radiotherapy orthopaedics iv diagnostics reagents active wound management advanced wound management (tissue engineering ...
» Purchase Premium Reports
(From $ 100 - $ 23 520)
About 3 200 reports
- $ 29 400
- Industry report
- March 2012
- by Venture Planning Group
During the next decade, the clinical chemistry and immunodiagnostics markets will undergo significant transformation. The changes will be caused convergence of new and more stringent regulations; advances ...
April 2012
$ 28 700
The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromagenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, ...
March 2012
$ 28 700
The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromagenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, ...
March 2012
$ 28 700
The infectious disease testing market is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers in the 21st century. Among the main ...
February 2012
$ 28 700
Complete report $28,700.  . This comprehensive seven-country report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the ...
March 2012
$ 28 500
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the ...
March 2012
$ 28 500
The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next ten years will witness significant developments in reagent systems and ...